tykhr
sign in
free sign up
Allogene Therapeutics Inc
Biotechnology
Healthcare
ALLO
209 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.36
52 week high
3.50
high
1.49
52 week low
1.36
low
1.23
growth
-43.20 %
previous Close
1.36
P/E ratio
market cap
409 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-66.29 M
0.10 %
eps
0.00 %
8.57 %
eps surprise
3.03 %
net profit margin
-6629300000.00 %
0.00 %
operating incoming
-71.77 M
-8.03 %
net change in cash
-119.43 M
-199.83 %
cash on hand
51.24 M
-69.98 %
cost of revenue
0.00 %
top